5,509 results on '"ANTIBODY diversity"'
Search Results
2. BCR signaling in germinal center B cell selection.
- Author
-
Inoue, Takeshi, Baba, Yoshihiro, and Kurosaki, Tomohiro
- Subjects
- *
B cell receptors , *ANTIBODY diversity , *B cells , *ANTIGEN receptors , *GERMINAL centers - Abstract
Germinal center (GC) B cells with functional B cell receptors (BCRs) transition from the dark zone (DZ) to the light zone (LZ) through BCR tonic-like signals (checkpoint 1). Antigen-induced BCR crosslinking provides a survival signal and primes LZ GC B cells to receive synergistic CD4+ follicular helper T (Tfh) cell help signals (checkpoint 2). A strong and sustained BCR signal induces reactive oxygen species (ROS)-mediated apoptosis, but this can be counteracted by the Tfh help signal (checkpoint 3). The balance between BCR and Tfh cell help signals ensures the clonal expansion that occurs in the DZ. Positive selection of germinal center B cells depends on the affinity of their antigen receptors. Emerging evidence shows that optimal B cell receptor (BCR) signaling, as well as a balance between BCR and T cell help signals, is necessary for antibody affinity maturation in the generation of antibody diversity. When mature B cells are activated by antigens, the selection of these activated B cells takes place particularly during T cell-dependent immune responses in which an improved antibody repertoire is generated through somatic hypermutation in germinal centers (GCs). In this process the importance of antigen presentation by GC B cells, and subsequent T follicular helper (Tfh) cell help in positive selection of GC B cells, has been well appreciated. By contrast, the role of B cell receptor (BCR) signaling per se remains unclear. Strong experimental support for the involvement of BCR signaling in GC B cell selection has now been provided. Interestingly, these studies suggest that several checkpoints operating through the BCR ensure affinity maturation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Missed opportunities to increase efficiency of monoclonal antibody development using hybridoma technology and mice as the source animal.
- Author
-
Chakravarty, Esha and Dorak, Mehmet T.
- Subjects
ANTIBODY diversity ,IMMUNOREGULATION ,SMALL cell lung cancer ,HISTOCOMPATIBILITY antigens ,IMMUNOGLOBULIN genes ,OVARIAN cancer - Abstract
This article explores missed opportunities in the development of monoclonal antibodies using mice and hybridoma technology. It emphasizes the importance of antigen presentation and the role of major histocompatibility complex (MHC) antigens in determining immunogenicity. The article suggests that using a diverse range of mouse strains or genetically engineered mouse models (GEMMs) could enhance antibody production. It also highlights the success of monoclonal antibody development in mice and proposes alternative approaches to generate a greater number of antibodies for diagnostic and therapeutic purposes. The authors clarify that their views are their own and do not represent their affiliated organizations or the publisher. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
4. High throughput long-read sequencing of circulating lymphocytes of the evolutionarily distant sea lamprey reveals diversity and common elements of the variable lymphocyte receptor B (VLRB) repertoire.
- Author
-
Zia, Amin, Orozco, Ariel, Fang, Irene S. Y., and Ehrhardt, Götz R. A.
- Subjects
ANTIBODY diversity ,B cells ,SEA lamprey ,CLINICAL medicine ,MEDICAL research - Abstract
The leucine-rich repeat-based variable lymphocyte receptor B (VLRB) antibody system of jawless vertebrates is capable of generating an antibody repertoire equal to or exceeding the diversity of antibody repertoires of jawed vertebrates. Unlike immunoglobulin-based immune repertoires, the VLRB repertoire diversity is characterized by variable lengths of VLRB encoding transcripts, rendering conventional immunoreceptor repertoire sequencing approaches unsuitable for VLRB repertoire sequencing. Here we demonstrate that long-read single-molecule real-time (SMRT) sequencing (PacBio) approaches permit the efficient large-scale assessment of the VLRB repertoire. We present a computational pipeline for sequence data processing and provide the first repertoire-based analysis of VLRB protein characteristics including properties of its subunits and regions of diversity within each structural leucine-rich repeat subunit. Our study provides a template to explore changes in the VLRB repertoire during immune responses and to establish large scale VLRB repertoire databases for computational approaches aimed at isolating monoclonal VLRB reagents for biomedical research and clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Antibody gene features associated with binding and functional activity in malaria vaccine-derived human mAbs.
- Author
-
Coelho, Camila H., Marquez, Susanna, Nguemwo Tentokam, Bergeline C., Berhe, Anne D., Miura, Kazutoyo, Rao, Vishal N., Long, Carole A., Doumbo, Ogobara K., Sagara, Issaka, Healy, Sara, Kleinstein, Steven H., and Duffy, Patrick E.
- Subjects
ANTIBODY diversity ,MALARIA vaccines ,MONOCLONAL antibodies ,MALARIA ,GERM cells - Abstract
The impact of adjuvants on malaria vaccine-induced antibody repertoire is poorly understood. Here, we characterize the impact of two adjuvants, Alhydrogel® and AS01, on antibody clonotype diversity, binding and function, post malaria vaccination. We expressed 132 recombinant anti-Pfs230D1 human monoclonal antibodies (mAbs) from participants immunized with malaria transmission-blocking vaccine Pfs230D1, formulated with either Alhydrogel® or AS01. Anti-Pfs230D1 mAbs generated by Alhydrogel® formulation showed higher binding frequency to Pfs230D1 compared to AS01 formulation, although the frequency of functional mAbs was similar between adjuvant groups. Overall, the AS01 formulation induced anti-Pfs230D1 functional antibodies from a broader array of germline sequences versus the Alhydrogel® formulation. All mAbs using IGHV1-69 gene from the Alhydrogel® cohort bound to recombinant Pfs230D1, but did not block parasite transmission to mosquitoes, similar to the IGHV1-69 mAbs isolated from the AS01 cohort. These findings may help inform vaccine design and adjuvant selection for immunization with Plasmodium antigens. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. The peculiar features, diversity and impact of citrulline-reactive autoantibodies.
- Author
-
Raposo, Bruno, Klareskog, Lars, Robinson, William H., Malmström, Vivianne, and Grönwall, Caroline
- Subjects
- *
ANTIBODY diversity , *AUTOANTIBODIES , *CYTOLOGY , *IMMUNE complexes , *PLASMA cells , *AUTOIMMUNE diseases - Abstract
Since entering the stage 25 years ago as a highly specific serological biomarker for rheumatoid arthritis, anti-citrullinated protein antibodies (ACPAs) have been a topic of extensive research. This hallmark B cell response arises years before disease onset, displays interpatient autoantigen variability, and is associated with poor clinical outcomes. Technological and scientific advances have revealed broad clonal diversity and intriguing features including high levels of somatic hypermutation, variable-domain N-linked glycosylation, hapten-like peptide interactions, and clone-specific multireactivity to citrullinated, carbamylated and acetylated epitopes. ACPAs have been found in different isotypes and subclasses, in both circulation and tissue, and are secreted by both plasmablasts and long-lived plasma cells. Notably, although some disease-promoting features have been reported, results now demonstrate that certain monoclonal ACPAs therapeutically block arthritis and inflammation in mouse models. A wealth of functional studies using patient-derived polyclonal and monoclonal antibodies have provided evidence for pathogenic and protective effects of ACPAs in the context of arthritis. To understand the roles of ACPAs, one needs to consider their immunological properties by incorporating different facets such as rheumatoid arthritis B cell biology, environmental triggers and chronic antigen exposure. The emerging picture points to a complex role of citrulline-reactive autoantibodies, in which the diversity and dynamics of antibody clones could determine clinical progression and manifestations. In this Review, the authors provide an overview of the immunological, clinical and pathophysiological features of anti-citrullinated protein antibodies in rheumatoid arthritis, highlighting the latest findings regarding the complex contribution of anti-citrullinated protein antibodies to the disease. Key points: Citrulline B cell responses are diverse but share important features that might be linked to rheumatoid arthritis-associated B cell dysregulation as well as environmental triggers, antigen exposure and the evolution of chronic immune reactions. Anti-citrullinated protein antibodies (ACPAs) are extensively multireactive towards citrullinated, carbamylated and acetylated proteins, have high somatic hypermutation, and carry N-linked glycosylations in the variable regions. More than 100 patient-derived human monoclonal ACPAs have been generated from different B cell compartments and patients, providing invaluable insights into citrulline autoimmunity and antibody function. Although disease-causative autoantigens are presently unknown, ACPAs can target different synovial cells and are likely to form pathogenic immune complexes. Results from studies using human monoclonal ACPAs reveal that some clones can completely block arthritis and inflammation in mouse models, while showing moderate pathogenic properties in other settings. Different ACPA clones with different immunological features and antigen-binding patterns might mediate disease-promoting effects or have protective roles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Systematic characterization of immunoglobulin loci and deep sequencing of the expressed repertoire in the Atlantic cod (Gadus morhua).
- Author
-
Györkei, Ádám, Johansen, Finn-Eirik, and Qiao, Shuo-Wang
- Subjects
- *
ATLANTIC cod , *ANTIBODY diversity , *T cells , *IMMUNOGLOBULIN genes , *IMMUNOGLOBULIN analysis , *GENE families , *T cell receptors - Abstract
Background: The Atlantic cod is a prolific species in the Atlantic, despite its inconsistent specific antibody response. It presents a peculiar case within vertebrate immunology due to its distinct immune system, characterized by the absence of MHCII antigen presentation pathway, required for T cell-dependent antibody responses. Thorough characterisation of immunoglobulin loci and analysis of the antibody repertoire is necessary to further our understanding of the Atlantic cod's immune response on a molecular level. Results: A comprehensive search of the cod genome (gadmor3.0) identified the complete set of IgH genes organized into three sequential translocons on chromosome 2, while IgL genes were located on chromosomes 2 and 5. The Atlantic cod displayed a moderate germline V gene diversity, comprising four V gene families for both IgH and IgL, each with distinct chromosomal locations and organizational structures. 5'RACE sequencing revealed a diverse range of heavy chain CDR3 sequences and relatively limited CDR3 diversity in light chains. The analysis highlighted a differential impact of V-gene germline CDR3 length on receptor CDR3 length between heavy and light chains, underlining different recombination processes. Conclusions: This study reveals that the Atlantic cod, despite its inconsistent antibody response, maintains a level of immunoglobulin diversity comparable to other fish species. The findings suggest that the extensive recent duplications of kappa light chain genes do not result in increased repertoire diversity. This research provides a comprehensive view of the Atlantic cod's immunoglobulin gene organization and repertoire, necessary for future studies of antibody responses at the molecular level. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy.
- Author
-
Lingbin Wang, Haojie Jiang, Xuying Yin, Tingting Liang, Guoming Li, Chen Ding, Mina Yang, Lin Zhang, Junling Liu, and Yanyan Xu
- Subjects
ANTIBODY diversity ,BISPECIFIC antibodies ,T cells ,IMMUNOTHERAPY ,IMMUNOGLOBULINS - Abstract
Introduction: Bispecific antibodies (BsAbs) can simultaneously target two epitopes of different antigenic targets, bringing possibilities for diversity in antibody drug design and are promising tools for the treatment of cancers and other diseases. T-cell engaging bsAb is an important application of the bispecific antibody, which could promote T cell-mediated tumor cell killing by targeting tumor-associated antigen (TAA) and CD3 at the same time. Methods: This study comprised antibodies purification, Elisa assay for antigen binding, cytotoxicity assays, T cell activation by flow cytometry in vitro and xenogenic tumor model in vivo. Results: We present a novel bsAb platform named PHE-Ig technique to promote cognate heavy chain (HC)-light chain (LC) pairing by replacing the CH1/CL regions of different monoclonal antibodies (mAbs) with the natural A and B chains of PHE1 fragment of Integrin b2 based on the knob-in-hole (KIH) technology. We had also verified that PHE-Ig technology can be effectively used as a platform to synthesize different desired bsAbs for T-cell immunotherapy. Especially, BCMA×CD3 PHE-Ig bsAbs exhibited robust antimultiple myeloma (MM) activity in vitro and in vivo. Discussion: Moreover, PHE1 domain was further shortened with D14G and R41S mutations, named PHE-S, and the PHE-S-based BCMA×CD3 bsAbs also showed anti BCMA
+ tumor effect in vitro and in vivo, bringing more possibilities for the development and optimization of different bsAbs. To sum up, PHE1-based IgGlike antibody platform for bsAb construction provides a novel strategy for enhanced T-cell immunotherapy. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
9. Construction and Validation of Chicken Immune scFv Antibody Library against Helicobacter pylori.
- Author
-
Gong, Yanan, Chen, Xiaoli, Fan, Jiaming, Sun, Lu, He, Lihua, Wang, Hairui, Yan, Xiaomei, and Zhang, Jianzhong
- Subjects
HELICOBACTER pylori ,CHICKENS ,ANTIBODY diversity ,RECOMBINANT proteins ,RECOMBINANT antibodies ,IMMUNOGLOBULINS ,MEDICAL screening - Abstract
Accurate diagnostic techniques and effective therapeutic methods are required to treat H. pylori. The application of chicken single-chain variable fragment (scFv) antibodies may diagnose and treat H. pylori. This study used the phage display technique to construct a chicken-derived immune scFv antibody library against H. pylori. Total RNA was extracted from the spleens of five immunized chickens and reverse transcribed into cDNA. A fragment of scFv was produced by overlap extension PCR and cloned into a pHEN2 phagemid vector. After the package with the M13KO7 helper phage, the recombinant HpaA protein was used as a target antigen to validate the screening ability of our antibody library by bio-panning. The dilution counting results showed that the size of the primary antibody library was estimated to be 1 × 10
9 cfu/mL. PCR analysis of 47 clones from the library revealed that about 100% of the clones were positive with scFv fragments, and there were no identical sequences, indicating the good diversity of the antibody library. After three rounds of bio-panning, high-affinity antibodies against recombinant HpaA protein were successfully obtained. The selected antibody specifically recognized HpaA protein in nine different H. pylori strains, confirming the screening ability of our library. The chicken immune scFv antibody library against H. pylori was successfully constructed, and the antibody library's screening ability was validated by selecting specific scFv antibodies against recombinant HpaA and clinical strains. It provided a simple and rapid method to obtain antibodies against H. pylori for diagnosis or treatment. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
10. An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries.
- Author
-
Petersen, Brian M., Kirby, Monica B., Chrispens, Karson M., Irvin, Olivia M., Strawn, Isabell K., Haas, Cyrus M., Walker, Alexis M., Baumer, Zachary T., Ulmer, Sophia A., Ayala, Edgardo, Rhodes, Emily R., Guthmiller, Jenna J., Steiner, Paul J., and Whitehead, Timothy A.
- Subjects
ANTIBODY diversity ,MOLECULAR recognition ,IMMUNOGLOBULINS ,IMMUNOTECHNOLOGY ,MONOCLONAL antibodies ,DEEP learning ,MUTAGENS - Abstract
Antibodies are engineerable quantities in medicine. Learning antibody molecular recognition would enable the in silico design of high affinity binders against nearly any proteinaceous surface. Yet, publicly available experiment antibody sequence-binding datasets may not contain the mutagenic, antigenic, or antibody sequence diversity necessary for deep learning approaches to capture molecular recognition. In part, this is because limited experimental platforms exist for assessing quantitative and simultaneous sequence-function relationships for multiple antibodies. Here we present MAGMA-seq, an integrated technology that combines multiple antigens and multiple antibodies and determines quantitative biophysical parameters using deep sequencing. We demonstrate MAGMA-seq on two pooled libraries comprising mutants of nine different human antibodies spanning light chain gene usage, CDR H3 length, and antigenic targets. We demonstrate the comprehensive mapping of potential antibody development pathways, sequence-binding relationships for multiple antibodies simultaneously, and identification of paratope sequence determinants for binding recognition for broadly neutralizing antibodies (bnAbs). MAGMA-seq enables rapid and scalable antibody engineering of multiple lead candidates because it can measure binding for mutants of many given parental antibodies in a single experiment. Limited experimental platforms exist for assessing quantitative sequence-function relationships for multiple antibodies. Here, authors develop a deep-sequencing based technology called MAGMA-seq, that determines the quantitative properties of antibody libraries. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Secreted novel AID/APOBEC-like deaminase 1 (SNAD1) - a new important player in fish immunology.
- Author
-
Majewska, Anna M., Dietrich, Mariola A., Budzko, Lucyna, Adamek, Mikołaj, Figlerowicz, Marek, and Ciereszko, Andrzej
- Subjects
FISH immunology ,ANTIBODY diversity ,GENE expression ,NUCLEIC acids ,GENETIC variation ,COLD-blooded animals - Abstract
The AID/APOBECs are a group of zinc-dependent cytidine deaminases that catalyse the deamination of bases in nucleic acids, resulting in a cytidine to uridine transition. Secreted novel AID/APOBEC-like deaminases (SNADs), characterized by the presence of a signal peptide are unique among all of intracellular classical AID/APOBECs, which are the central part of antibody diversity and antiviral defense. To date, there is no available knowledge on SNADs including protein characterization, biochemical characteristics and catalytic activity. We used various in silico approaches to define the phylogeny of SNADs, their common structural features, and their potential structural variations in fish species. Our analysis provides strong evidence of the universal presence of SNAD1 proteins/transcripts in fish, in which expression commences after hatching and is highest in anatomical organs linked to the immune system. Moreover, we searched published fish data and identified previously, "uncharacterized proteins" and transcripts as SNAD1 sequences. Our review into immunological research suggests SNAD1 role in immune response to infection or immunization, and interactions with the intestinal microbiota. We also noted SNAD1 association with temperature acclimation, environmental pollution and sex-based expression differences, with females showing higher level. To validate in silico predictions we performed expression studies of several SNAD1 gene variants in carp, which revealed distinct patterns of responses under different conditions. Dual sensitivity to environmental and pathogenic stress highlights its importance in the fish and potentially enhancing thermotolerance and immune defense. Revealing the biological roles of SNADs represents an exciting new area of research related to the role of DNA and/or RNA editing in fish biology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Design and Evaluation of Chimeric Plasmodium falciparum Circumsporozoite Protein-Based Malaria Vaccines.
- Author
-
Stump, William H., Klingenberg, Hayley J., Ott, Amy C., Gonzales, Donna M., and Burns Jr., James M.
- Subjects
MALARIA vaccines ,HEPATITIS associated antigen ,PLASMODIUM falciparum ,ANTIBODY diversity ,CIRCUMSPOROZOITE protein - Abstract
Efficacy data on two malaria vaccines, RTS,S and R21, targeting Plasmodium falciparum circumsporozoite protein (PfCSP), are encouraging. Efficacy may be improved by induction of additional antibodies to neutralizing epitopes outside of the central immunodominant repeat domain of PfCSP. We designed four rPfCSP-based vaccines in an effort to improve the diversity of the antibody response. We also evaluated P. falciparum merozoite surface protein 8 (PfMSP8) as a malaria-specific carrier protein as an alternative to hepatitis B surface antigen. We measured the magnitude, specificity, subclass, avidity, durability, and efficacy of vaccine-induced antibodies in outbred CD1 mice. In comparison to N-terminal- or C-terminal-focused constructs, immunization with near full-length vaccines, rPfCSP (#1) or the chimeric rPfCSP/8 (#2), markedly increased the breadth of B cell epitopes recognized covering the N-terminal domain, junctional region, and central repeat. Both rPfCSP (#1) and rPfCSP/8 (#2) also elicited a high proportion of antibodies to conformation-dependent epitopes in the C-terminus of PfCSP. Fusion of PfCSP to PfMSP8 shifted the specificity of the T cell response away from PfCSP toward PfMSP8 epitopes. Challenge studies with transgenic Plasmodium yoelii sporozoites expressing PfCSP demonstrated high and consistent sterile protection following rPfCSP/8 (#2) immunization. Of note, antibodies to conformational C-terminal epitopes were not required for protection. These results indicate that inclusion of the N-terminal domain of PfCSP can drive responses to protective, repeat, and non-repeat B cell epitopes and that PfMSP8 is an effective carrier for induction of high-titer, durable anti-PfCSP antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. RAGging on recombination signal sequence strength for diffusion‐mediated recombination.
- Author
-
Jackson, Katherine JL
- Subjects
- *
T-cell receptor genes , *IMMUNOGLOBULIN light chains , *ANTIBODY diversity , *CHROMOSOME inversions , *IMMUNOGLOBULIN heavy chains , *T cell receptors , *KILLER cell receptors - Abstract
This article discusses the mechanisms of gene segment utilization in lymphocyte repertoires and focuses on the recombination-activating genes (RAG) and their role in the generation of adaptive receptor genes. The study specifically examines the recombination process in the immunoglobulin kappa chain (IGK) locus and compares it to the immunoglobulin heavy chain (IGH) locus. The researchers found that primary IGK rearrangements in mice are mediated by a diffusional RAG process that allows for both inversional and deletional rearrangement. They also discovered that the IGK locus has evolved stronger recombination signal sequences (RSS) compared to the IGH locus, which are essential for diffusion-mediated RAG processing. The findings shed light on the mechanisms of primary repertoire formation and the impact of genetic variation on immune receptor repertoires. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
14. Immune aging in annual killifish.
- Author
-
Morabito, Gabriele, Ryabova, Alina, and Valenzano, Dario Riccardo
- Subjects
- *
IMMUNOSENESCENCE , *KILLIFISHES , *ANTIBODY diversity , *CELLULAR aging , *AGING , *IMMUNE system - Abstract
Turquoise killifish (Nothobranchius furzeri) evolved a naturally short lifespan of about six months and exhibit aging hallmarks that affect multiple organs. These hallmarks include protein aggregation, telomere shortening, cellular senescence, and systemic inflammation. Turquoise killifish possess the full spectrum of vertebrate-specific innate and adaptive immune system. However, during their recent evolutionary history, they lost subsets of mucosal-specific antibody isoforms that are present in other teleosts. As they age, the immune system of turquoise killifish undergoes dramatic cellular and systemic changes. These changes involve increased inflammation, reduced antibody diversity, an increased prevalence of pathogenic microbes in the intestine, and extensive DNA damage in immune progenitor cell clusters. Collectively, the wide array of age-related changes occurring in turquoise killifish suggest that, despite an evolutionary separation spanning hundreds of millions of years, teleosts and mammals share common features of immune system aging. Hence, the spontaneous aging observed in the killifish immune system offers an excellent opportunity for discovering fundamental and conserved aspects associated with immune system aging across vertebrates. Additionally, the species' naturally short lifespan of only a few months, along with its experimental accessibility, offers a robust platform for testing interventions to improve age-related dysfunctions in the whole organism and potentially inform the development of immune-based therapies for human aging-related diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Multi‐objective optimization method for control parameters of flexible direct current transmission converters based on intelligent algorithms.
- Author
-
Yu, Linlin, Tang, Xiaojun, Si, Ruihua, Xie, Yan, Jia, Peng, Li, Lixin, Huo, Qidi, and Zhu, Shaoxuan
- Subjects
- *
SYSTEM failures , *ANTIBODY diversity , *ALTERNATING currents , *EVOLUTIONARY algorithms , *ELECTRIC power distribution grids , *POWER transmission - Abstract
In order to meet the current needs of power transmission, people have turned their attention to direct current (DC) transmission. When the alternating current(AC) power grid (PG) fails, it is easy to cause commutation failure in the DC system, thereby increasing the fault scope of the system. Therefore, this article adopts a flexible DC transmission system. Flexible DC converters have many control parameters, and there are mutual influences and conflicts between these parameters. By applying intelligent algorithms to multi‐objective optimization (MOP), these complex MOP problems can be effectively solved and an optimal set of control parameter combinations can be found. This method has an important contribution and novelty for optimizing the converter control parameters of flexible DC transmission systems. This article achieves fast and accurate MOP of the control parameters of flexible DC transmission converters by continuously detecting the similarities between antibodies and maintaining the diversity of the population. The research results show that the average DC side current is about 405A in the first 20 seconds, and the DC side current fluctuates regularly after 20 seconds. This article lays the foundation for establishing a real‐time simulation model of flexible DC transmission systems suitable for real‐time simulation systems. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
- Author
-
Masashi Shingai, Sayaka Iida, Naoko Kawai, Mamiko Kawahara, Toshiki Sekiya, Marumi Ohno, Naoki Nomura, Chimuka Handabile, Tomomi Kawakita, Ryosuke Omori, Junya Yamagishi, Kaori Sano, Akira Ainai, Tadaki Suzuki, Kazuo Ohnishi, Kimihito Ito, and Hiroshi Kida
- Subjects
- *
VIRUS diseases , *ANTIBODY diversity , *INFLUENZA viruses , *VIRAL antibodies , *MICE , *PROBABILITY density function , *ANTIBODY titer - Abstract
Historically, antibody reactivity to pathogens and vaccine antigens has been evaluated using serological measurements of antigen-specific antibodies. However, it is difficult to evaluate all antibodies that contribute to various functions in a single assay, such as the measurement of the neutralizing antibody titer. Bulk antibody repertoire analysis using next-generation sequencing is a comprehensive method for analyzing the overall antibody response; however, it is unreliable for estimating ant igen-specific antibodies due to individual variation. To address this issue, we propose a method to subtract the background signal from the repertoire of data of interest. In this study, we analyzed changes in antibody diversity and inferred the heavy-chain complementarity-determining region 3 (CDRH3) sequences of antibody clones that were selected upon influenza virus infection in a mouse model using bulk repertoire analysis. A decrease in the diversity of the antibody repertoire was observed upon viral infection, along with an increase in neutralizing antibody titers. Using kernel density estimation of sequences in a high-dimensional sequence space with background signal subtraction, we identified several clusters of CDRH3 sequences induced upon influenza virus infection. Most of these repertoires were detected more frequently in infected mice than in uninfected control mice, suggesting that infection-specific antibody sequences can be extracted using this method. Such an accurate extraction of antigen- or infect ion-specific repertoire information will be a useful tool for vaccine evaluation in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Atypical memory B cell frequency correlates with antibody breadth and function in malaria immune adults.
- Author
-
Partey, Frederica Dedo, Dowuona, Jasmine Naa Norkor, Pobee, Abigail Naa Adjorkor, Walker, Melanie Rose, Aculley, Belinda, Prah, Diana Ahu, Ofori, Michael Fokuo, and Barfod, Lea Klingenberg
- Subjects
- *
B cells , *IMMUNOLOGIC memory , *ANTIBODY diversity , *MALARIA , *IMMUNOGLOBULINS , *CELL populations - Abstract
Clinical immunity to malaria develops slowly after repeated episodes of infection and antibodies are essential in naturally acquired immunity against malaria. However, chronic exposure to malaria has been linked to perturbation in B-cell homeostasis with the accumulation of atypical memory B cells. It is unclear how perturbations in B cell subsets influence antibody breadth, avidity, and function in individuals naturally exposed to malaria. We show that individuals living in high malaria transmission regions in Ghana have higher Plasmodium falciparum merozoite antigen-specific antibodies and an increased antibody breadth score but lower antibody avidities relative to low transmission regions. The frequency of circulating atypical memory B cells is positively associated with an individual's antibody breadth. In vitro growth inhibition is independent of the ability to bind to free merozoites but associated with the breadth of antibody reactivity in an individual. Taken together, our data shows that repeated malaria episodes hamper the development of high avid antibodies which is compensated for by an increase in antibody breadth. Our results provide evidence to reinforce the idea that in regions with high malaria prevalence, repeated malaria infections lead to the broadening of antibody diversity and the continued presence of atypical memory B cell populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil.
- Author
-
da Costa Castilho, Marcia, Bispo de Filippis, Ana Maria, Ceschini Machado, Lais, Vasconcelos de Lima Calvanti, Thaise Yasmine, Costa Lima, Morganna, Fonseca, Vagner, Giovanetti, Marta, Docena, Cassia, Menezes Neto, Armando, Aguiar Bôtto-Menezes, Camila Helena, Oliveira Kara, Edna, de La Barrera, Rafael, Modjarrad, Kayvon, Pereira Giozza, Silvana, Fernando Pereira, Gerson, Junior Alcantara, Luiz Carlos, Nicole Broutet, Nathalie Jeanne, Amaral Calvet, Guilherme, Luz Wallau, Gabriel, and Oliveira Franca, Rafael Freitas
- Subjects
- *
ANTIBODY diversity , *ZIKA virus , *ANTIBODY formation , *ZIKA virus infections , *REINFECTION , *ANTICARDIOLIPIN antibodies - Abstract
We generated 238 Zika virus (ZIKV) genomes from 135 persons in Brazil who had samples collected over 1 year to evaluate virus persistence. Phylogenetic inference clustered the genomes together with previously reported ZIKV strains from northern Brazil, showing that ZIKV has been remained relatively stable over time. Temporal phylogenetic analysis revealed limited within-host diversity among most ZIKV-persistent infected associated samples. However, we detected unusual virus temporal diversity from >5 persons, uncovering the existence of divergent genomes within the same patient. All those patients showed an increase in neutralizing antibody levels, followed by a decline at the convalescent phase of ZIKV infection. Of interest, in 3 of those patients, titers of neutralizing antibodies increased again after 6 months of ZIKV infection, concomitantly with real-time reverse transcription PCR re-positivity, supporting ZIKV reinfection events. Altogether, our findings provide evidence for the existence of ZIKV reinfection events. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Polymeric immunoglobulin receptor (pIgR) in cancer.
- Author
-
Chae, Jisu, Choi, Jinny, and Chung, Junho
- Subjects
- *
IMMUNOGLOBULIN receptors , *ANTIBODY diversity , *ESOPHAGEAL cancer , *GENE expression , *EPHRINS , *OVARIAN cancer , *CANCER cells - Abstract
Background: The polymeric immunoglobulin receptor (pIgR) is a transmembrane transporter of polymeric IgA through the intestinal epithelium. Its overexpression has been reported in several cancers, but its role as a diagnostic and prognostic biomarker of oncogenesis is currently unclear. Method: A literature search was conducted to summarize the functions of pIgR, its expression levels, and its clinical implications. Results: pIgR expression has previously been investigated by proteomic analysis, RNA sequencing, and tissue microarray at the level of both RNA and protein in various cancers including pancreatic, esophageal, gastric, lung, and liver. However, studies have reported inconsistent results on how pIgR levels affect clinical outcomes such as survival rate and chemotherapy resistance. Possible explanations include pIgR mRNA levels being minimally correlated with the rate of downstream pIgR protein synthesis, and the diversity of antibodies used in immunohistochemistry studies further magnifying this ambiguity. In ovarian cancer cells, the transcytosis of IgA accompanied a series of transcriptional changes in intracellular inflammatory pathways that inhibit the progression of cancer, including the upregulation of IFN-gamma and downregulation of tumor-promoting ephrins. These findings suggest that both the levels of pIgR and secreted IgA from tumor-infiltrating B cells affect clinical outcomes. Conclusion: Overall, no direct correlation was observed between the levels of pIgR inside tumor tissue and the clinical features in cancer patients. Measuring pIgR protein levels with a more specific and possibly chemically defined antibody, along with tumoral IgA, is a potential solution to better understand the pathways and consequences of pIgR overexpression in cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
- Author
-
Kan Li, Huntwork, Richard H. C., Horn, Gillian Q., Abraha, Milite, Hastie, Kathryn M., Haoyang Li, Rayaprolu, Vamseedhar, Olmedillas, Eduardo, Feeney, Elizabeth, Cronin, Kenneth, Schende, Sharon L., Heise, Mark, Bedinger, Daniel, Mattocks, Melissa D., Baric, Ralph S., Alam, S. Munir, Saphire, Erica Ollmann, Tomaras, Georgia D., and Dennison, S. Moses
- Subjects
- *
RECEPTOR antibodies , *ANTIBODY diversity , *SARS-CoV-2 , *MONOCLONAL antibodies , *IMMUNOGLOBULINS , *COVID-19 pandemic , *SURFACE interactions , *VIRAL antibodies - Abstract
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has accumulated more than 700 million infection cases and 6.9 million deaths. New variants have affecte d antibody interaction with the surface spike protein. We defined the domain specificities and measured hexa-proline stabilized spike protein (HexaPro) binding kinetics of a large panel of antibodies sourced by the Coronavirus Immunotherapeutics Consortium. Epitope binning analysis of antibodies competing for HexaPro binding separated the fine specificities of the majority of antibodies to four regions: top, outer, mesa/valley, or cryptic site of receptor binding domain (RBD). Most of the topRBDspecific antibodies showed >3-fold loss of binding and authentic-virus neutralization activity for the B.1.351 variant. Remarkably, among RBD mesa/valleyspecific or crypticsitespecific antibodies, 55% showed >3-fold stronger affinities, and at least 60% maintained neutralization activity for the B.1.351 variant. These data also highlighted the diversity of SARSCoV2specific antibodies that retain high spike affinities and antiviral functions across variants. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. A quantitative comparison of antibodies against epitope tags for immunofluorescence detection.
- Author
-
Marchetti, Anna, Lima, Wanessa C., Hammel, Philippe, and Cosson, Pierre
- Subjects
ANTIBODY diversity ,RECOMBINANT antibodies ,IMMUNOFLUORESCENCE ,IMMOBILIZED proteins ,IMMUNOGLOBULINS ,CHIMERIC proteins - Abstract
Epitope tags recognized by specific antibodies have been widely used over the last few decades, notably to localize tagged proteins within cells by immunofluorescence. The diversity of tags and antibodies usually prevents a side‐by‐side comparison of the efficiency with which each antibody recognizes its cognate tag. We expressed chimeric proteins, each composed of an invariant domain (IL2Ra) associated with a specific epitope tag. Double immunofluorescence allowed us to quantify in parallel the reference signal generated by the anti‐IL2Ra antibody and the signal generated by the anti‐epitope tag antibody. Since all antibodies used in this study were recombinant antibodies fused to the same mouse Fc domain, the generated signals were directly comparable. Three groups of tags/antibodies were revealed: 'good' antibodies generated high signals even when used at a low concentration (50 ng·mL−1), 'fair' antibodies generated a high signal only at high concentrations (5000 ng·mL−1), and 'mediocre' antibodies generated positive but weak signals. Except for an anti‐myc antibody, similar results were obtained when cells were fixed in paraformaldehyde or methanol. These results provide a side‐by‐side quantitative evaluation of different tag/antibody pairs. This information will be useful to optimize the choice of epitope tags and to choose optimal antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Genome-wide epitope mapping across multiple host species reveals significant diversity in antibody responses to Coxiella burnetii vaccination and infection.
- Author
-
Bach, Emil, Fitzgerald, Stephen F., Williams-MacDonald, Sarah E., Mitchell, Mairi, Golde, William T., Longbottom, David, Nisbet, Alasdair J., Dinkla, Annemieke, Sullivan, Eric, Pinapati, Richard S., Tan, John C., Joosten, Leo A. B., Roest, Hendrik-Jan, Østerbye, Thomas, Koets, Ad P., Buus, Søren, and McNeilly, Tom N.
- Subjects
ANTIBODY diversity ,COXIELLA burnetii ,ANTIBODY formation ,Q fever ,PROTEIN microarrays ,SCHMALLENBERG virus ,HUMORAL immunity ,CATTLE - Abstract
Coxiella burnetii is an important zoonotic bacterial pathogen of global importance, causing the disease Q fever in a wide range of animal hosts. Ruminant livestock, in particular sheep and goats, are considered the main reservoir of human infection. Vaccination is a key control measure, and two commercial vaccines based on formalin-inactivated C. burnetii bacterins are currently available for use in livestock and humans. However, their deployment is limited due to significant reactogenicity in individuals previously sensitized to C. burnetii antigens. Furthermore, these vaccines interfere with available serodiagnostic tests which are also based on C. burnetii bacterin antigens. Defined subunit antigen vaccines offer significant advantages, as they can be engineered to reduce reactogenicity and co-designed with serodiagnostic tests to allow discrimination between vaccinated and infected individuals. This study aimed to investigate the diversity of antibody responses to C. burnetii vaccination and/or infection in cattle, goats, humans, and sheep through genome-wide linear epitope mapping to identify candidate vaccine and diagnostic antigens within the predicted bacterial proteome. Using high-density peptide microarrays, we analyzed the seroreactivity in 156 serum samples from vaccinated and infected individuals to peptides derived from 2,092 open-reading frames in the C. burnetii genome. We found significant diversity in the antibody responses within and between species and across different types of C. burnetii exposure. Through the implementation of three different vaccine candidate selection methods, we identified 493 candidate protein antigens for protein subunit vaccine design or serodiagnostic evaluation, of which 65 have been previously described. This is the first study to investigate multi-species seroreactivity against the entire C. burnetii proteome presented as overlapping linear peptides and provides the basis for the selection of antigen targets for next-generation Q fever vaccines and diagnostic tests. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Autoantibody Diversity Is Augmented in Women with Breast Cancer and Is Related to the Stage of the Disease.
- Author
-
Pérez-Hernández, Jesús, León-Díaz, Rosalba, Zentella, Alejandro, Lamoyi, Edmundo, Esquivel-Velázquez, Marcela, Barranca-Enríquez, Antonia, and Romo-González, Tania
- Subjects
- *
AUTOANTIBODIES , *ANTIBODY diversity , *CANCER patients , *DISEASE progression , *ANTIBODY formation - Abstract
Breast cancer (BC) is the most frequent malignant neoplasia and leading cause of cancer mortality for women. A timely diagnosis of BC is crucial to ensure the best chances of survival. Among the various screening tools for BC, antibodies directed towards self-antigens or tumor-associated antigens (autoantibodies) have emerged as an alternative to image-based screening modalities. However, little attention has been paid to the global diversity of autoantibodies. This work aimed to analyze the diversity of autoantibodies reactive to antigens expressed by the BC cell line T47D in the sera of Mexican women with BC, benign breast pathology (BBP), or without breast pathology (WBP). We found that the diversity of antibodies in the sera was higher in the BC and BBP groups than in the WBP group. Likewise, the diversity changed with the progression of BC. Our results show and measure the complexity of the antibody response in breast health and disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses.
- Author
-
Spatola, Marianna, Nziza, Nadège, Jung, Wonyeong, Deng, Yixiang, Yuan, Dansu, Dinoto, Alessandro, Bozzetti, Silvia, Chiodega, Vanessa, Ferrari, Sergio, Lauffenburger, Douglas A, Mariotto, Sara, and Alter, Galit
- Subjects
- *
SARS-CoV-2 , *CORONAVIRUS diseases , *COVID-19 , *ANTIBODY diversity , *CORONAVIRUSES - Abstract
Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global public health emergency. Although SARS-CoV-2 is primarily a respiratory pathogen, extra-respiratory organs, including the CNS, can also be affected. Neurologic symptoms have been observed not only during acute SARS-CoV-2 infection, but also at distance from respiratory disease, also known as long-COVID or neurological post-acute sequelae of COVID-19 (neuroPASC). The pathogenesis of neuroPASC is not well understood, but hypotheses include SARS-CoV-2-induced immune dysfunctions, hormonal dysregulations and persistence of SARS-CoV-2 reservoirs. In this prospective cohort study, we used a high throughput systems serology approach to dissect the humoral response to SARS-CoV-2 (and other common coronaviruses: 229E, HKU1, NL63 and OC43) in the serum and CSF from 112 infected individuals who developed (n = 18) or did not develop (n = 94) neuroPASC. Unique SARS-CoV-2 humoral profiles were observed in the CSF of neuroPASC compared with serum responses. All antibody isotypes (IgG, IgM, IgA) and subclasses (IgA1–2, IgG1–4) were detected in serum, whereas CSF was characterized by focused IgG1 (and absence of IgM). These data argue in favour of compartmentalized brain-specific responses against SARS-CoV-2 through selective transfer of antibodies from the serum to the CSF across the blood–brain barrier, rather than intrathecal synthesis, where more diversity in antibody classes/subclasses would be expected. Compared to individuals who did not develop post-acute complications following infection, individuals with neuroPASC had similar demographic features (median age 65 versus 66.5 years, respectively, P = 0.55; females 33% versus 44%, P = 0.52) but exhibited attenuated systemic antibody responses against SARS-CoV-2, characterized by decreased capacity to activate antibody-dependent complement deposition (ADCD), NK cell activation (ADNKA) and to bind Fcγ receptors. However, surprisingly, neuroPASC individuals showed significantly expanded antibody responses to other common coronaviruses, including 229E, HKU1, NL63 and OC43. This biased humoral activation across coronaviruses was particularly enriched in neuroPASC individuals with poor outcome, suggesting an 'original antigenic sin' (or immunologic imprinting), where pre-existing immune responses against related viruses shape the response to the current infection, as a key prognostic marker of neuroPASC disease. Overall, these findings point to a pathogenic role for compromised anti-SARS-CoV-2 responses in the CSF, likely resulting in incomplete virus clearance from the brain and persistent neuroinflammation, in the development of post-acute neurologic complications of SARS-CoV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. The immunogenicity of human-origin therapeutic antibodies are associated with V gene usage.
- Author
-
Zicheng Hu, Cohen, Sivan, and Swanson, Steven J.
- Subjects
IMMUNE response ,ANTIBODY diversity ,IMMUNOGLOBULINS ,IMMUNOTECHNOLOGY ,IMMUNE system - Abstract
Therapeutic antibodies can elicit unwanted immune responses in a subset of patients, which leads to the production of anti-drug antibodies (ADA). Some of these ADAs have been reported to effect the pharmacokinetics, efficacy and/or safety of the therapeutic antibodies. The sequence diversity of antibodies are generated by VDJ recombination and mutagenesis. While the antibody generation process can create a large candidate pool for identifying high-affinity antibodies, it also could produce sequences that are foreign to the human immune system. However, it is not clear how VDJ recombination and mutagenesis impact the clinical ADA rate of therapeutic antibodies. In this study, we identified a positive correlation between the clinical ADA rate and the number of introduced mutations in the antibody sequences. We also found that the use of rare V alleles in human-origin antibody therapeutics is associated with higher risk of immunogenicity. The results suggest that antibody engineering projects should start with frameworks that contain commonly used V alleles and prioritize antibody candidates with low number of mutations to reduce the risk of immunogenicity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Engaging an HIV vaccine target through the acquisition of low B cell affinity.
- Author
-
Ronsard, Larance, Yousif, Ashraf S., Nait Mohamed, Faez Amokrane, Feldman, Jared, Okonkwo, Vintus, McCarthy, Caitlin, Schnabel, Julia, Caradonna, Timothy, Barnes, Ralston M., Rohrer, Daniel, Lonberg, Nils, Schmidt, Aaron, and Lingwood, Daniel
- Subjects
B cells ,B cell receptors ,ANTIBODY diversity ,TARGET acquisition ,AIDS vaccines ,HIV ,IMMUNOLOGIC memory - Abstract
Low affinity is common for germline B cell receptors (BCR) seeding development of broadly neutralizing antibodies (bnAbs) that engage hypervariable viruses, including HIV. Antibody affinity selection is also non-homogenizing, insuring the survival of low affinity B cell clones. To explore whether this provides a natural window for expanding human B cell lineages against conserved vaccine targets, we deploy transgenic mice mimicking human antibody diversity and somatic hypermutation (SHM) and immunize with simple monomeric HIV glycoprotein envelope immunogens. We report an immunization regimen that focuses B cell memory upon the conserved CD4 binding site (CD4bs) through both conventional affinity maturation and reproducible expansion of low affinity BCR clones with public patterns in SHM. In the latter instance, SHM facilitates target acquisition by decreasing binding strength. This suggests that permissive B cell selection enables the discovery of antibody epitopes, in this case an HIV bnAb site. Broadly neutralizing antibodies (bnAbs) for HIV have been difficult to elicit with one issue being the low B cell affinity required. Here the authors use a transgenic mouse bearing human-like antibody repertoires to show that low affinity B cells persist which enables vaccine expansion of antibodies against the CD4 binding site, a conserved HIV bnAb target. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.
- Author
-
Romer, Guadalupe, Bracco, Leonel A., Ricci, Alejandro D., Balouz, Virginia, Berná, Luisa, Villar, Juan C., Ramsey, Janine M., Nolan, Melissa S., Torrico, Faustino, Kesper, Norival, Altcheh, Jaime, Robello, Carlos, Buscaglia, Carlos A., and Agüero, Fernán
- Subjects
- *
CHAGAS' disease , *TRYPANOSOMA cruzi , *ANTIBODY diversity , *EPITOPES , *PROTEIN microarrays - Abstract
Background: Trypanosoma cruzi, the agent of Chagas disease, displays a highly structured population, with multiple strains that can be grouped into 6–7 evolutionary lineages showing variable eco-epidemiological traits and likely also distinct disease-associated features. Previous works have shown that antibody responses to 'isoforms' of the polymorphic parasite antigen TSSA enable robust and sensitive identification of the infecting strain with near lineage-level resolution. To optimize the serotyping performance of this molecule, we herein used a combination of immunosignaturing approaches based on peptide microarrays and serum samples from Chagas disease patients to establish a deep linear B-cell epitope profiling of TSSA. Methods/Principle findings: Our assays revealed variations in the seroprevalence of TSSA isoforms among Chagas disease populations from different settings, hence strongly supporting the differential distribution of parasite lineages in domestic cycles across the Americas. Alanine scanning mutagenesis and the use of peptides of different lengths allowed us to identify key residues involved in antibody pairing and the presence of three discrete B-cell linear epitopes in TSSAII, the isoform with highest seroprevalence in human infections. Comprehensive screening of parasite genomic repositories led to the discovery of 9 novel T. cruzi TSSA variants and one TSSA sequence from the phylogenetically related bat parasite T. cruzi marinkellei. Further residue permutation analyses enabled the identification of diagnostically relevant or non-relevant substitutions among TSSA natural polymorphisms. Interestingly, T. cruzi marinkellei TSSA displayed specific serorecognition by one chronic Chagas disease patient from Colombia, which warrant further investigations on the diagnostic impact of such atypical TSSA. Conclusions/Significance: Overall, our findings shed new light into TSSA evolution, epitope landscape and modes of recognition by Chagas disease patients; and have practical implications for the design and/or evaluation of T. cruzi serotyping strategies. Author summary: Chagas disease, caused by the protozoan Trypanosoma cruzi, is a chronic, debilitating illness of major significance in Latin America. Due to the extensive genetic and phenotypic variability of this parasite, methods able to reliably assign the infecting strain type are expected to have a positive effect on epidemiologic surveillance, prevention of transmission, and clinical management of Chagas disease. Herein we describe the diversity of human antibody specificities directed to a polymorphic T. cruzi antigen, TSSA, using a combination of bioinformatics and state of the art immunoassays based on peptide arrays. Our results led to the identification of novel variants of the antigen, distinct epitopes, and their key residues for antibody binding across diverse human populations and have practical implications for the design and/or evaluation of T. cruzi serotyping strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire.
- Author
-
Rodriguez, Oscar L., Safonova, Yana, Silver, Catherine A., Shields, Kaitlyn, Gibson, William S., Kos, Justin T., Tieri, David, Ke, Hanzhong, Jackson, Katherine J. L., Boyd, Scott D., Smith, Melissa L., Marasco, Wayne A., and Watson, Corey T.
- Subjects
IMMUNOGLOBULIN heavy chains ,GENETIC variation ,SINGLE nucleotide polymorphisms ,ANTIBODY diversity ,IMMUNOGLOBULINS ,ANTIBODY formation ,MONOCLONAL antibodies ,T cell receptors - Abstract
Variation in the antibody response has been linked to differential outcomes in disease, and suboptimal vaccine and therapeutic responsiveness, the determinants of which have not been fully elucidated. Countering models that presume antibodies are generated largely by stochastic processes, we demonstrate that polymorphisms within the immunoglobulin heavy chain locus (IGH) impact the naive and antigen-experienced antibody repertoire, indicating that genetics predisposes individuals to mount qualitatively and quantitatively different antibody responses. We pair recently developed long-read genomic sequencing methods with antibody repertoire profiling to comprehensively resolve IGH genetic variation, including novel structural variants, single nucleotide variants, and genes and alleles. We show that IGH germline variants determine the presence and frequency of antibody genes in the expressed repertoire, including those enriched in functional elements linked to V(D)J recombination, and overlapping disease-associated variants. These results illuminate the power of leveraging IGH genetics to better understand the regulation, function, and dynamics of the antibody response in disease. Haplotype diversity in the human immunoglobulin heavy chain (IGH) locus is poorly characterized. Here, the authors use long-read sequencing to discover extensive IGH diversity and link germline variants to variation in the antibody repertoire. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Mechanistic insights from molecular microbiology into the production of immunological and neuronal diversity.
- Author
-
Dorman, Charles J.
- Subjects
- *
MOLECULAR microbiology , *ANTIBODY diversity , *GENE expression , *BACTERIAL genes , *EPIGENETICS , *PROKARYOTES - Abstract
Bacteria deal with an unpredictable, and often hostile, environment by being unpredictable themselves. This article will link some contributions made by variable DNA topology and nucleoid‐associated proteins to the generation of stochasticity in bacterial gene expression and describe how the associated mechanistic insights can elucidate the means by which diversity in antibody and neuronal cell development might be produced in humans and other higher organisms. The focus here will not be on mutation; instead, the article will address epigenetic effects on gene expression brought about by the modulation of topoisomerase activity in both prokaryotes and eukaryotes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Structure-aware tools for the development of therapeutic antibodies from natural immunoglobulins
- Author
-
Raybould, Matthew Ian James and Deane, Charlotte
- Subjects
616.07 ,Immunoinformatics ,Antibody diversity ,Molecular structure - Abstract
In this thesis, we establish the foundations for structure-based antibody drug discovery from natural immunoglobulin sequences. This is achieved through two novel software packages: 'Repertoire Structural Profiling' (RSP), as a means of generating structurally-diverse virtual screening libraries, and the 'Therapeutic Antibody Profiler' (TAP), for rapid structure-aware developability assessment of candidates in early-stage antibody drug discovery. Our approaches are orthogonal to existing work in these fields and yield new insights into the diversity of the adaptive immune system and the physicochemical characteristics of therapeutic antibodies. We also describe a new database (Thera-SAbDab), which provides the increased therapeutic antibody sequence and structural data necessary to benchmark RSP and TAP, and to facilitate future investigations in the area. Finally, we report our work in the COVID-19 response effort, which, through a novel database of thousands of coronavirus antibody-binders (CoV-AbDab), has already contributed functional annotations to SARS-CoV-2 immune response repertoires.
- Published
- 2020
31. Absence of terminal deoxynucleotidyl transferase expression in T‐ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
- Author
-
Xiao, Hui, Wang, Siqi, Tang, Yuejia, Li, Shanshan, Jiang, Yufeng, Yang, Yi, Zhang, Yinwen, Han, Yali, Wu, Xiaoyu, Zheng, Liang, Li, Yanxin, and Gao, Yijin
- Subjects
DRUG resistance ,HEMATOPOIETIC stem cell transplantation ,IMMUNOGLOBULIN genes ,DNA repair ,ANTIBODY diversity ,CD19 antigen - Abstract
T‐acute lymphoblastic leukemia/lymphoma (T‐ALL/LBL) is a malignant neoplasm of immature lymphoblasts. Terminal deoxynucleotidyl transferase (TDT) is a template‐independent DNA polymerase that plays an essential role in generating diversity for immunoglobulin genes. T‐ALL/LBL patients with TDT− have a worse prognosis. However, how TDT− promotes the disease progression of T‐ALL/LBL remains unknown. Here we analyzed the prognosis of T‐ALL/LBL patients in Shanghai Children's Medical Center (SCMC) and confirmed that TDT− patients had a higher rate of recurrence and remission failure and worse outcomes. Cellular experiments demonstrated that TDT was involved in DNA damage repair. TDT knockout delayed DNA repair, arrested the cell cycle and decreased apoptosis to induce the accumulation of chromosomal abnormalities and tolerance to abnormal karyotypes. Our study demonstrated that the poor outcomes in TDT− T‐ALL/LBL might be due to the drug resistance (VP16 and MTX) induced by chromosomal abnormalities. Our findings revealed novel functions and mechanisms of TDT in T‐ALL/LBL and supported that hematopoietic stem cell transplantation (HSCT) might be a better choice for these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Single-domain antibody-based noninvasive in vivo imaging of α-synuclein or tau pathology.
- Author
-
Yixiang Jiang, Yan Lin, Krishnaswamy, Senthilkumar, Ruimin Pan, Qian Wu, Sandusky-Beltran, Leslie A., Mengyu Liu, Min-Hao Kuo, Xiang-Peng Kong, Congdon, Erin E., and Sigurdsson, Einar M.
- Subjects
- *
NEUROFIBRILLARY tangles , *ALPHA-synuclein , *PATHOLOGY , *LEWY body dementia , *ANTIBODY diversity , *TAU proteins , *SMALL molecules - Abstract
The article presents a study which developed noninvasive in vivo imaging ligands via phage display libraries derived from llamas immunized with α-synuclein and tau preparations, respectively. Topics discussed include α#-synuclein versus tau immunization and single-domain antibody (sdAb) characterization, imaging studies by In Vivo Imaging System (IVIS), and histological analysis of sdAb brain signal.
- Published
- 2023
- Full Text
- View/download PDF
33. Structural characterisation of hemagglutinin from seven Influenza A H1N1 strains reveal diversity in the C05 antibody recognition site.
- Author
-
Ghafoori, Seyed Mohammad, Petersen, Gayle F., Conrady, Deborah G., Calhoun, Brandy M., Stigliano, Matthew Z. Z., Baydo, Ruth O., Grice, Rena, Abendroth, Jan, Lorimer, Donald D., Edwards, Thomas E., and Forwood, Jade K.
- Subjects
- *
ANTIBODY diversity , *H1N1 influenza , *AVIAN influenza , *CELL receptors , *HEMAGGLUTININ , *VACCINE development - Abstract
Influenza virus (IV) causes several outbreaks of the flu each year resulting in an economic burden to the healthcare system in the billions of dollars. Several influenza pandemics have occurred during the last century and estimated to have caused 100 million deaths. There are four genera of IV, A (IVA), B (IVB), C (IVC), and D (IVD), with IVA being the most virulent to the human population. Hemagglutinin (HA) is an IVA surface protein that allows the virus to attach to host cell receptors and enter the cell. Here we have characterised the high-resolution structures of seven IVA HAs, with one in complex with the anti-influenza head-binding antibody C05. Our analysis revealed conserved receptor binding residues in all structures, as seen in previously characterised IV HAs. Amino acid conservation is more prevalent on the stalk than the receptor binding domain (RBD; also called the head domain), allowing the virus to escape from antibodies targeting the RBD. The equivalent site of C05 antibody binding to A/Denver/57 HA appears hypervariable in the other H1N1 IV HAs. Modifications within this region appear to disrupt binding of the C05 antibody, as these HAs no longer bind the C05 antibody by analytical SEC. Our study brings new insights into the structural and functional recognition of IV HA proteins and can contribute to further development of anti-influenza vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models.
- Author
-
Mukadam, Aamir S., Miller, Lauren V. C., Smith, Annabel E., Vaysburd, Marina, Sakya, Siri A., Sanford, Sophie, Keeling, Sophie, Tuck, Benjamin J., Katsinelos, Taxiarchis, Green, Chris, Skov, Lise, Kaalund, Sanne S., Foss, Stian, Mayes, Keith, O’Connell, Kevin, Wing, Mark, Knox, Claire, Banbury, Jessica, Avezov, Edward, and Rowe, James B.
- Subjects
- *
IMMUNOGLOBULINS , *NEURODEGENERATION , *CELL aggregation , *BLOOD proteins , *ANTIBODY diversity - Abstract
Aggregates of the protein tau are proposed to drive pathogenesis in neurodegenerative diseases. Tau can be targeted by using passively transferred antibodies (Abs), but the mechanisms of Ab protection are incompletely understood. In this work, we used a variety of cell and animal model systems and showed that the cytosolic Ab receptor and E3 ligase TRIM21 (T21) could play a role in Ab protection against tau pathology. Tau-Ab complexes were internalized to the cytosol of neurons, which enabled T21 engagement and protection against seeded aggregation. Ab-mediated protection against tau pathology was lost in mice that lacked T21. Thus, the cytosolic compartment provides a site of immunotherapeutic protection, which may help in the design of Ab-based therapies in neurodegenerative disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs.
- Author
-
von Gunten, Stephan, Schneider, Christoph, Imamovic, Lejla, and Gorochov, Guy
- Subjects
ANTIBODY diversity ,INTRAVENOUS immunoglobulins ,SEROTHERAPY ,IMMUNOGLOBULIN A ,COLONIZATION (Ecology) - Abstract
Significant progress has been made in the elucidation of human antibody repertoires. Furthermore, non-canonical functions of antibodies have been identified that reach beyond classical functions linked to protection from pathogens. Polyclonal immunoglobulin preparations such as IVIG and SCIG represent the IgG repertoire of the donor population and will likely remain the cornerstone of antibody replacement therapy in immunodeficiencies. However, novel evidence suggests that pooled IgA might promote orthobiotic microbial colonization in gut dysbiosis linked to mucosal IgA immunodeficiency. Plasma-derived polyclonal IgG and IgA exhibit immunoregulatory effects by a diversity of different mechanisms, which have inspired the development of novel drugs. Here we highlight recent insights into IgG and IgA repertoires and discuss potential implications for polyclonal immunoglobulin therapy and inspired drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. 基于免疫算法的电网拓扑结构识别.
- Author
-
董宸, 吴强, 黄河, 章锐, and 杨秀媛
- Subjects
ELECTRIC power distribution grids ,ANTIBODY diversity ,SITUATIONAL awareness ,ELECTRICAL load ,INTELLIGENT control systems ,PARTICLE swarm optimization - Abstract
Copyright of Power Generation Technology is the property of Power Generation Technology Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
37. Identification and characterization of IgNAR and VNAR repertoire from the ocellate spot skate (Okamejei kenojei)
- Author
-
Jianqing Wen, Jinyu Gong, Pengwei Li, Penghui Deng, Mengsi Sun, Yujie Wu, Chenxi Tian, Hao Wang, and Yunchen Bi
- Subjects
IgNAR ,VNAR ,skate ,VNAR structure ,antibody diversity ,Science ,General. Including nature conservation, geographical distribution ,QH1-199.5 - Abstract
Elasmobranchs are crucial for comparative studies of evolution, as they belong to the most ancient vertebrate lineages that survived numerous extinction events and persist until today. The immunoglobulin new antigen receptor (IgNAR) found in sharks and heavy-chain-only antibody (HCAb) found in camelidae are products of convergent evolution. Although it was previously believed that IgNAR emerged 220 million years ago, before the divergence of sharks and skates, there is limited evidence to support this. In this study, we provide data supporting the existence of IgNAR in the ocellate spot skate (Okamejei kenojei) mononuclear cell transcriptome and peripheral blood serum. Additionally, we characterize the germline gene configuration of the ocellate spot skate IgNAR V domain. The ocellate spot skate IgNAR structure prediction and VNAR crystal structure exhibit high similarity to their shark counterparts. These data strongly suggest that IgNAR in both sharks and skates share a common ancestor. Sequencing of the ocellate spot skate VNAR repertoire provided crucial data for further understanding of the IgNAR generation. Notably, we discovered that approximately 99% of the ocellate spot skate VNARs belonged to type IV. This represents an exceptionally high proportion of type IV within the VNAR repertoire, which has not been documented in previously studied elasmobranchs. This unique characteristic of the ocellate spot skate VNAR adds essential structural diversity to the naïve VNAR library from elasmobranchs and could potentially benefit the development of pharmaceutical drugs.
- Published
- 2023
- Full Text
- View/download PDF
38. Editorial: Population and action mechanism of immune cells in fish.
- Author
-
Zejun Zhou, Yu Huang, Ruijuan Hao, Chuangye Yang, Abarike, Emmanuel Delwin, and Jun Li
- Subjects
ANTIBODY diversity ,KILLER cells ,B cell differentiation ,AQUATIC resource management ,ANIMAL disease control ,LECTINS - Abstract
This article, titled "Editorial: Population and action mechanism of immune cells in fish," provides an overview of recent research on the immune cells of fish. The article highlights the differences in immune cell action mechanisms between fish and mammals, emphasizing the importance of studying fish for comparative immunological studies. The research topics covered in the article include the components of the innate and adaptive immune systems in fish, the role of complement components in immune cell function, the antiviral immune response in fish, and the mechanisms regulating B cell homing in fish. The insights presented in this article contribute to a better understanding of fish innate and adaptive immunity and can serve as a source of inspiration for understanding the evolution of immune systems in vertebrates. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
39. Antibody multispecificity: A necessary evil?
- Author
-
Jaiswal, Deepika, Verma, Sheenam, Nair, Deepak T., and Salunke, Dinakar M.
- Subjects
- *
IMMUNOGLOBULINS , *HUMORAL immunity , *MONOCLONAL antibodies , *VIROIDS , *ANTIBODY diversity , *IMMUNE response , *IMMUNE system - Abstract
Antibodies represent key effectors of the adaptive immune system. The specificity of antibodies is an established hallmark of the immune response. However, a certain proportion of antibodies exhibit limited promiscuity or multireactivity. Germline antibodies display plasticity which imparts multispecificity to enhance the antibody repertoire. Surprisingly, even affinity matured antibodies display such plasticity and multireactivity enabling their binding to more than one antigen. We propose that antibody multispecificity is a physiological requirement to expand the antibody repertoire at the germline level and to tolerate plasticity in antigens at the mature level. This property of the humoral immune response may attenuate the ability of infectious RNA viruses such as influenza, HIV and SARS-CoV-2 to acquire mutations that render resistance to neutralizing antibodies. • Antibodies (Abs) ensure specificity and fidelity of immune response. • Multispecificity is a physiological requirement of the immune system. • Ability of germline Abs to recognize distinct antigens enhances Ab diversity. • Multispecificity of mature Abs may retard evolution of highly mutable pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Antibody class-switching as a strategy to improve HIV-1 neutralization.
- Author
-
Scheepers, Cathrine, Richardson, Simone I., Moyo-Gwete, Thandeka, and Moore, Penny L.
- Subjects
- *
ANTIBODY diversity , *HIV , *IMMUNE response , *IMMUNOGLOBULINS , *IMMUNE system - Abstract
Broadly neutralizing antibodies (bNAbs), when administered through passive immunization, are protective against HIV-1 infection. Current HIV-1 vaccine strategies are aimed at guiding the immune system to make bNAbs by mimicking their development during infection. Somatic hypermutation of the variable region is known to be crucial for the development of bNAbs. More recently, however, studies have shown how class-switch recombination (CSR) resulting in the generation of different antibody isotypes may serve as an additional mechanism through which antibodies can gain neutralization breadth and potency. In this review, we discuss the importance of different antibody isotypes for HIV-1 neutralization breadth and potency and how this information can be leveraged to improve passive and active immunization against HIV-1. Class-switch recombination (CSR), which involves maintaining the antigen-binding variable region and swapping out the constant region of antibodies, enables diversity in immune responses to disease. Antibody isotype diversity is associated with increased neutralization breadth towards pathogens such as HIV-1. The constant region of antibodies, previously thought to only mediate Fc effector function, can also influence the neutralization breadth and potency of HIV-1-directed antibodies. Within HIV-1 directed antibody lineages, CSR represents another mechanism through which antibodies can counter viral immune escape. Antibody IgG3 and IgA1 isotypes mediate enhanced function through different mechanisms. IgG3 relies on increased flexibility, while IgA1 depends on conformational changes within the paratope. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. The major role of junctional diversity in the horse antibody repertoire.
- Author
-
Navas, Carlena, Manso, Taciana, Martins, Fabio, Minto, Lucas, Moreira, Rennan, Minozzo, João, Antunes, Bruno, Vale, André, McDaniel, Jonathan R., Ippolito, Gregory C., and Felicori, Liza F.
- Subjects
- *
ANTIBODY diversity , *B cell receptors , *IMMUNOGLOBULINS , *HORSE breeds , *HORSES , *HORSE breeding - Abstract
The antibody repertoire (Rep-seq) sequencing revolutionized the diversity of antigen B cell receptor studies, allowing deep and quantitative analysis to decipher the role of adaptive immunity in health and disease. Particularly, horse (Equus caballus) polyclonal antibodies have been produced and used since the century XIX to treat and prophylaxis diphtheria, tuberculosis, tetanus, pneumonia, and, more recently, COVID-19. However, our knowledge about the horse B cell receptors repertories is minimal. We present a deep horse antibody heavy chain repertoire (IGH) characterization of non-infected horses using NGS (Next generation sequencing). This study obtained a mean of 248,169 unique IgM clones and 66,141 unique IgG clones from four domestic adult horses. Rarefaction analysis showed sequence coverage was between 52 % and 82 % in IgM and IgG isotypes. We observed that besides horses antibody can use all functional IGHV genes, around 80 % of their antibodies use only three IGHV gene segments, and around 55 % use only one IGHJ gene segment. This limited VJ diversity seems to be compensated by the junctional diversity of these antibodies. We observed that the junctional diversity in horse antibodies is widespread, present in more than 90 % of horse antibodies. Besides this, the length of this region seems to be higher in horse antibodies than in other species. N1 and N2 nucleotides addition range from 0 to 111 nucleotides. In addition, around 45 % of the antibody clones have more than ten nucleotides in both the N1 and N2 junction regions. This diversity mechanism may be one of the most important in providing variability to the equine antibody repertoire. This study provides new insights regarding horse antibody composition, diversity generation, and particularities compared to other species, such as the frequency and length of N nucleotide addition. This study also points out the urgent need to better characterize TdT in horses and other species to better understand antibody repertoire characteristics. • Horse antibodies have a restrict VJ gene usage. • Only 3 different IGHV4 and the IGHJ6 genes are used for most of the horses antibodies. • The junctional diversity in horse antibodies looks bigger compared to other species. • More than 80% of horse antibodies use IGHD reading frame 1. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens.
- Author
-
Lewitus, Eric, Hoang, Jennifer, Li, Yifan, Bai, Hongjun, and Rolland, Morgane
- Subjects
- *
HIV , *ANTIBODY diversity , *IMMUNOGLOBULINS , *ANTIGENS , *VACCINE effectiveness , *VACCINES - Abstract
The immense global diversity of HIV-1 is a significant obstacle to developing a safe and effective vaccine. We recently showed that infections established with multiple founder variants are associated with the development of neutralization breadth years later. We propose a novel vaccine design strategy that integrates the variability observed in acute HIV-1 infections with multiple founder variants. We developed a probabilistic model to simulate this variability, yielding a set of sequences that present the minimal diversity seen in an infection with multiple founders. We applied this model to a subtype C consensus sequence for the Envelope (Env) (used as input) and showed that the simulated Env sequences mimic the mutational landscape of an infection with multiple founder variants, including diversity at antibody epitopes. The derived set of multi-founder-variant-like, minimally distant antigens is designed to be used as a vaccine cocktail specific to a HIV-1 subtype or circulating recombinant form and is expected to promote the development of broadly neutralizing antibodies. Author summary: Diverse HIV-1 populations are generally thought to promote neutralizing responses. Current leading HIV-1 vaccine design strategies maximize the distance between antigens to attempt to cover global HIV-1 diversity or serialize immunizations to recapitulate the temporal evolution of HIV-1 during infection. To date, no vaccine has elicited broadly neutralizing antibodies. As we recently demonstrated that infection with multiple HIV-1 founder variants is predictive of neutralization breadth, we propose a novel strategy that endeavors to promote the development of broadly neutralizing antibodies by replicating the diversity of multi-founder variant acute infections. By training an HIV-1 Env consensus sequence on the diversity from acute infections with multiple founders, we derived in silico a set of minimally distant antigens that is representative of the diversity seen in a multi-founder acute infection. As the model is particular to the input sequence, it can produce antigens specific to any HIV-1 subtype or circulating recombinant form (CRF). We applied this to HIV-1 subtype C and obtained a set of minimally distant antigens that can be used as a vaccine cocktail. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
43. Honing-in antigen-specific cells during antibody discovery: a user-friendly process to mine a deeper repertoire.
- Author
-
Mahendra, Ankit, Haque, Aftabul, Prabakaran, Ponraj, Mackness, Brian C., Fuller, Thomas P., Liu, Xiaohua, Kathuria, Sagar V., Wang, Yui-Hsi, Amatya, Nilesh, Yu, Xiaocong, Hopke, Joern, Hoffmann, Dietmar, Bric-Furlong, Eva, Zhang, Ningning, Cho, Hyun-Suk, Zhang, Ruijun, Sancho, Jose, Saleh, Jacqueline, Rao, Sambasiva P., and Wendt, Maria
- Subjects
- *
ANTIBODY diversity , *MINING methodology , *PROCESS mining , *B cells , *MOLECULAR cloning , *TECHNOLOGICAL innovations - Abstract
Immunization based antibody discovery is plagued by the paucity of antigen-specific B cells. Identifying these cells is akin to finding needle in a haystack. Current and emerging technologies while effective, are limited in terms of capturing the antigen-specific repertoire. We report on the bulk purification of antigen-specific B-cells and the benefits it offers to various antibody discovery platforms. Using five different antigens, we show hit rates of 51–88%, compared to about 5% with conventional methods. We also show that this purification is highly efficient with loss of only about 2% antigen specific cells. Furthermore, we compared clones in which cognate chains are preserved with those from display libraries in which chains either from total B cells (TBC) or antigen-specific B cells (AgSC) underwent combinatorial pairing. We found that cognate chain paired clones and combinatorial clones from AgSC library had higher frequency of functional clones and showed greater diversity in sequence and paratope compared to clones from the TBC library. This antigen-specific B-cell selection technique exemplifies a process improvement with reduced cycle time and cost, by removing undesired clones prior to screening and increasing the chance of capturing desirable and rare functional clones in the repertoire. The authors developed a methodology for bulk enrichment of antigen-specific B cells to improve the diversity of antibody sequences and increase the number of functional antigen-specific antibodies coming from different antibody generation platforms. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
44. Evolution of surrogate light chain in tetrapods and the relationship between lengths of CDR H3 and VpreB tails.
- Author
-
Ott, Jeannine A., Haakenson, Jeremy K., Kelly, Abigail R., Christian, Claire, Criscitiello, Michael F., and Smider, Vaughn V.
- Subjects
ANTIBODY diversity ,TETRAPODS ,CELL receptors ,GENETIC variation ,B cells - Abstract
In the mammalian immune system, the surrogate light chain (SLC) shapes the antibody repertoire during B cell development by serving as a checkpoint for production of functional heavy chains (HC). Structural studies indicate that tail regions of VpreB contact and cover the third complementarity-determining region of the HC (CDR H3). However, some species, particularly bovines, have CDR H3 regions that may not be compatible with this HC-SLC interaction model. With immense structural and genetic diversity in antibody repertoires across species, we evaluated the genetic origins and sequence features of surrogate light chain components. We examined tetrapod genomes for evidence of conserved gene synteny to determine the evolutionary origin of VpreB1, VpreB2, and IGLL1, as well as VpreB3 and pre-T cell receptor alpha (PTCRA) genes. We found the genes for the SLC components (VpreB1, VpreB2, and IGLL1) only in eutherian mammals. However, genes for PTCRA occurred in all amniote groups and genes for VpreB3 occurred in all tetrapod groups, and these genes were highly conserved. Additionally, we found evidence of a new VpreB gene in non-mammalian tetrapods that is similar to the VpreB2 gene of eutherian mammals, suggesting VpreB2 may have appeared earlier in tetrapod evolution and may be a precursor to traditional VpreB2 genes in higher vertebrates. Among eutherian mammals, sequence conservation between VpreB1 and VpreB2 was low for all groups except rabbits and rodents, where VpreB2 was nearly identical to VpreB1 and did not share conserved synteny with VpreB2 of other species. VpreB2 of rabbits and rodents likely represents a duplicated variant of VpreB1 and is distinct from the VpreB2 of other mammals. Thus, rabbits and rodents have two variants of VpreB1 (VpreB1-1 and VpreB1-2) but no VpreB2. Sequence analysis of VpreB tail regions indicated differences in sequence content, charge, and length; where repertoire data was available, we observed a significant relationship between VpreB2 tail length and maximum DH length. We posit that SLC components co-evolved with immunoglobulin HC to accommodate the repertoire -- particularly CDR H3 length and structure, and perhaps highly unusual HC (like ultralong HC of cattle) may bypass this developmental checkpoint altogether. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
45. Exploiting V -Gene Bias for Rapid, High-Throughput Monoclonal Antibody Isolation from Horses.
- Author
-
Wibmer, Constantinos Kurt and Mashilo, Poppy
- Subjects
- *
ANTIBODY diversity , *IMMUNOGLOBULIN G , *EMERGING infectious diseases , *HORSE breeds , *IMMUNOGLOBULIN genes , *HORSES , *MONOCLONAL antibodies - Abstract
Horses and humans share a close relationship that includes both species' viromes. Many emerging infectious diseases can be transmitted between horses and humans and can exhibit mortality rates as high as 90% in both populations. Antibody biologics represents an emerging field of rapidly discoverable and potent antiviral therapeutics. These biologics can be used to provide passive immunity, as well as blueprints for the rational design of novel active vaccine antigens. Here, we exploit the limited diversity of immunoglobulin variable genes used by horses to develop a rapid, high-throughput monoclonal antibody discovery pipeline. The antibodies isolated from two horses in this study were developed with near exclusivity from a few highly related germline genes within a single IgHV and IgλV gene family and could be recovered for cloning with just three primer pairs. This variable gene pairing was compatible with both horse and human immunoglobulin G isotypes, confirming the suitability of an equine antibody discovery pipeline for developing novel therapeutics to meet the One Health approach to infectious diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
46. Antibodies: A History of Their Discovery and Properties
- Author
-
Rees, Anthony, Rüker, Florian, editor, and Wozniak-Knopp, Gordana, editor
- Published
- 2021
- Full Text
- View/download PDF
47. Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies
- Author
-
Prohaska, Thomas A, Que, Xuchu, Diehl, Cody J, Hendrikx, Sabrina, Chang, Max W, Jepsen, Kristen, Glass, Christopher K, Benner, Christopher, and Witztum, Joseph L
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Immunology ,Prevention ,Immunization ,Vaccine Related ,Vaccine Related (AIDS) ,Biotechnology ,Genetics ,HIV/AIDS ,Aetiology ,2.1 Biological and endogenous factors ,Amino Acid Sequence ,Animals ,Antibodies ,Antibody Diversity ,B-Lymphocyte Subsets ,Base Sequence ,Female ,Genes ,Immunoglobulin ,Immunoglobulin Heavy Chains ,Immunoglobulin Variable Region ,Mice ,Mice ,Inbred C57BL ,Spleen ,Biochemistry and cell biology - Abstract
B-1 cells are a unique subset of B cells that are positively selected for expressing autoreactive BCRs. We isolated RNA from peritoneal (B-1a, B-1b, B-2) and splenic (B-1a, marginal zone, follicular) B cells from C57BL/6 mice and used 5'-RACE to amplify the IgH V region using massively parallel sequencing. By analyzing 379,000 functional transcripts, we demonstrate that B-1a cells use a distinct and restricted repertoire. All B-1 cell subsets, especially peritoneal B-1a cells, had a high proportion of sequences without N additions, suggesting predominantly prenatal development. Their transcripts differed markedly and uniquely contained VH11 and VH12 genes, which were rearranged only with a restricted selection of D and J genes, unlike other V genes. Compared to peritoneal B-1a, the peritoneal B-1b repertoire was larger, had little overlap with B-1a, and most sequences contained N additions. Similarly, the splenic B-1a repertoire differed from peritoneal B-1a sequences, having more unique sequences and more frequent N additions, suggesting influx of B-1a cells into the spleen from nonperitoneal sites. Two CDR3s, previously described as Abs to bromelain-treated RBCs, comprised 43% of peritoneal B-1a sequences. We show that a single-chain variable fragment designed after the most prevalent B-1a sequence bound oxidation-specific epitopes such as the phosphocholine of oxidized phospholipids. In summary, we provide the IgH V region library of six murine B cell subsets, including, to our knowledge for the first time, a comparison between B-1a and B-1b cells, and we highlight qualities of B-1 cell Abs that indicate unique selection processes.
- Published
- 2018
48. Immunoglobulin γ marker genes as effect modifiers of Epstein–Barr virus‐multiple sclerosis association.
- Author
-
Pandey, Janardan P.
- Subjects
- *
GENES , *HEREDITY , *IMMUNOGLOBULIN genes , *GENE rearrangement , *ANTIBODY diversity , *IMMUNOGLOBULIN class switching - Abstract
Thus, our hypothesis would predict that among EBV seropositive individuals, those expressing the GM 1,21 haplotype would be at a significantly enhanced risk of developing MS, compared to those who express the alternative GM 3,5 haplotype. Keywords: EBV; GM allotypes; latent allotypes; MS EN EBV GM allotypes latent allotypes MS 242 244 3 05/22/23 20230601 NES 230601 Abbreviations CSF cerebrospinal fluid EBV Epstein-Barr virus GM marker GWAS genome-wide association studies IGHG immunoglobulin heavy chain G MS multiple sclerosis PCR-RFLP polymerase chain reaction-restriction fragment length polymorphism INTRODUCTION Involvement of Epstein-Barr virus (EBV) in the etiopathogenesis of multiple sclerosis (MS) has been suspected for decades. TESTING THE HYPOTHESIS THAT GM GENES ARE EFFECT MODIFIERS OF EBV-MS ASSOCIATION MS patients are frequently characterized by the enhanced intrathecal synthesis of IgG, a key biological feature of the disease. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
49. Use of live viral vaccines after HCT: Still a lot to learn.
- Author
-
Sabaini, Paula Moreira da Silva and Machado, Clarisse M.
- Subjects
- *
VIRAL vaccines , *RUBELLA vaccines , *COMMUNICABLE diseases , *YELLOW fever , *ANTIBODY diversity , *ANTI-vaccination movement - Abstract
Revaccination program after HCT is necessary due to the loss of lifelong immunity acquired by previous vaccination or infections. The program is complex and even in a favourable scenario, it takes more than 2 years to be completed. As the complexity of HCT increases (alternative donors, diversity of monoclonal antibodies), studies evaluating the response to vaccination in this population are welcome, especially those that evaluate live attenuated vaccines given their scarcity. Furthermore, measles, mumps, rubella and even yellow fever, and poliomyelitis outbreaks have perplexed infectious diseases clinicians and epidemiologists globally, most of them due to the decline in vaccination coverage rates in children and adults, because of the growth of antivaccine movements around the world. The study of Lin et al. adds important information about measles, mumps and rubella vaccination after HCT. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. The Binding Landscape of Serum Antibodies: How Physical and Mathematical Concepts Can Advance Systems Immunology.
- Author
-
Prechl, József, Papp, Krisztián, Kovács, Ágnes, and Pfeil, Tamás
- Subjects
- *
ANTIBODY diversity , *BLOOD proteins , *IMMUNOGLOBULINS , *PHYSICAL & theoretical chemistry , *IMMUNOLOGY - Abstract
Antibodies constitute a major component of serum on protein mass basis. We also know that the structural diversity of these antibodies exceeds that of all other proteins in the body and they react with an immense number of molecular targets. What we still cannot quantitatively describe is how antibody abundance is related to affinity, specificity, and cross reactivity. This ignorance has important practical consequences: we also do not have proper biochemical units for characterizing polyclonal serum antibody binding. The solution requires both a theoretical foundation, a physical model of the system, and technology for the experimental confirmation of theory. Here we argue that the quantitative characterization of interactions between serum antibodies and their targets requires systems-level physical chemistry approach and generates results that should help create maps of antibody binding landscape. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.